Profile
ASRT ZTS TAK HLN TEVA NBIX
Company Name Assertio Holdings, Inc. Zoetis Inc. Takeda Pharmaceutical Company Limited Haleon plc Teva Pharmaceutical Industries Limited Neurocrine Biosciences, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $77.04M $75.04B $41.18B $41.12B $23.19B $14.48B
Employees 0.05K 14.10K 49.28K 25.41K 37.00K 1.70K
CEO Mr. Brendan P. O'Grady Ms. Kristin C. Peck Mr. Christophe Weber Mr. Brian James McNamara Mr. Richard D. Francis Mr. Kyle W. Gano Ph.D.
Ratings
ASRT ZTS TAK HLN TEVA NBIX
Quant Rating Score 2 3 3 3 1 3
Quant Rating Sell Neutral Neutral Neutral Strong Sell Neutral
Trading
ASRT ZTS TAK HLN TEVA NBIX
Last Close $0.8069 $166.32 $12.99 $9.1 $20.44 $143.03
High 52 $1.75 $199.94 $15.08 $10.69 $22.77 $153.15
Low 52 $0.75 $145.54 $12.6 $8.01 $10.99 $111.62
Price vs. 52 Week High -53.89 % -16.82 % -13.86 % -14.87 % -10.23 % -6.61 %
Price vs. 52 Week Low 7.59 % 14.28 % 3.1 % 13.61 % 85.99 % 28.14 %
Total Return
ASRT ZTS TAK HLN TEVA NBIX
1 Month Return -12.29 % -6.66 % -3.2 % -6.76 % 23.88 % 12.89 %
3 Month Return -27.96 % -13.67 % -9.41 % -9.9 % 18.56 % 22.84 %
6 Month Return -51.39 % -7.1 % -3.35 % 2.25 % 18.29 % -2.98 %
9 Month Return -7.06 % 10.89 % -2.84 % 13.61 % 53.68 % 6.22 %
YTD Return -7.37 % 2.08 % -1.89 % -4.61 % -7.26 % 4.78 %
1 Year Return -10.88 % -16.4 % -13.63 % 5.32 % 80.57 % 8.33 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ASRT ZTS TAK HLN TEVA NBIX
Dividend Yield Percentage (TTM) - 1.04 % 4.66 % 1.69 % - -
Dividend Paid and Capex Coverage Ration (TTM) 114.26 % 2.1 % 1.34 % - 3.8 % 13.12 %
Dividend Per Share (TTM) - 1.73 % 192 % 0.06 % - -
Payout Ratio (TTM) - 31.44 % 101.62 % - - -
Growth
ASRT ZTS TAK HLN TEVA NBIX
Asset Growth -30.8 % -4.28 % 8.25 % -2.18 % -1.2 % 37.27 %
Gross Profit Growth -9.05 % 3.7 % 1.76 % 5.84 % 9.65 % 26.06 %
Revenue Growth -2.67 % 5.74 % 5.87 % 4.09 % 6.17 % 26.76 %
Revenue 3 Year -47.2 % 31.98 % 33.13 % 13.9 % -6.91 % 71.93 %
Revenue 5 Year -89.05 % 53.64 % 103.83 % 32.87 % -23.33 % 308.36 %
Revenue 10 Year -77.37 % 103.1 % 152.69 % 32.87 % -40.82 % 44100.16 %
EBIT Growth -521.24 % 6.27 % -56.36 % 9.37 % -84.52 % 0.76 %
Net Income Growth -402.8 % 10.88 % -54.56 % -1.04 % 76.24 % 61.62 %
Net Income 3 Yeari Growth Per Share -335.19 % 47.55 % -61.74 % -8.67 % 86.29 % -41.58 %
Net Income 5 Yeari Growth Per Share -301.94 % 71.94 % 32.36 % 59.66 % 76.28 % 1054.95 %
Net Income 10 Yeari Growth Per Share -253.04 % 404.24 % 35.42 % 59.66 % -133.42 % 470.4 %
Operating Income Growth -521.24 % 6.27 % -56.36 % 9.37 % -84.52 % 0.76 %
Operating Cash Flow Growth (CFG) -36.89 % 23.06 % -26.69 % 1.79 % -13.96 % 14.88 %
Operating 3 Year CFG 127.91 % 14.12 % -29.25 % 48.8 % 10.09 % 62.6 %
Operating 5 Year CFG -84.64 % 37.69 % 118.64 % 166.36 % -48.98 % 275.6 %
Operating 10 Year CFG 1.55 % 274.61 % 384.17 % 166.36 % -67.94 % 1000.37 %
EPS Growth -300.43 % 12.64 % -54.92 % - 76.42 % 59.01 %
EPS Diluted Growth -332.34 % 12.92 % -54.86 % - 76.42 % 58.33 %
Book Value Per Share -59.54 % 15.25 % 13.54 % 1.35 % -7.25 % 28.15 %
Share Holder 3 Year Equity Growth Per Share -8.28 % 36.7 % 40.38 % -36.6 % -26.74 % 88.86 %
Share Holder 5 Year Equity Growth Per Share -85.94 % 139.55 % 41.33 % -39.41 % -53.44 % 353.33 %
Share Holder 10 Year Equity Growth Per Share -79.95 % 476.36 % 195.14 % -39.41 % -74.76 % 1167.34 %
Dividend Per Share Growth - 15.15 % 1.95 % -85.58 % - -
Dividend 3 Year Growth Per Share - 87.76 % 1.19 % -83.69 % - -
Dividend 5 Year Growth Per Share - 198.29 % 101.42 % -66.42 % -100 % -
Dividend 10 Year Growth Per Share - 665.58 % 102.58 % -66.42 % -100 % -
Debt Growth -38.82 % -16.5 % 10.53 % -9.43 % -6.53 % 62.95 %
Free Cash Flow Growth -37.47 % 22.25 % -31.4 % 1.67 % -19.19 % 11.99 %
Updated On 31 Dec 2023 31 Dec 2023 31 Mar 2024 31 Dec 2023 31 Dec 2023 31 Dec 2023
Profitability
ASRT ZTS TAK HLN TEVA NBIX
Gross Profit Margin TTM 61.85 % 68.87 % 55.23 % 60.68 % 49.84 % 98 %
Return on Assets TTM -24.81 % 16.93 % 1.99 % 3.26 % -2.38 % 10.92 %
Return on Equity TTM -51.19 % 47.99 % 4.04 % 6.54 % -14.6 % 15.68 %
Return on Capital Employed TTM -8.83 % 26.36 % 4.18 % 7.22 % 1.6 % 18.91 %
Net Income Per EBT TTM 160.45 % 79.65 % 108.74 % 65.38 % 176.38 % 73.98 %
EBT Per Ebit TTM 260.05 % 91.46 % 52.35 % 82.95 % -125.67 % 88.81 %
EBIT Per Revenue TTM -13.05 % 36.45 % 11.21 % 17.82 % 2.67 % 26.19 %
Cash Flow To Debt Ratio TTM 52.95 % 43.6 % 16.58 % - 9.78 % -
Receivables Turnover TTM 2.8 6.49 6.3 5.27 4.84 4.66
Payables Turnover TTM 3.65 7.05 4.92 1.23 3.55 0.47
Inventory Turnover TTM 1.21 1.18 1.69 3.03 2.12 0.98
Fixed Asset Turnover TTM 7041.6 % 259.93 % 240.84 % 604.62 % 277.85 % 664.93 %
Asset Turnover TTM 45.57 % 63.75 % 31.2 % 33.71 % 40.16 % 63.45 %
Operating Cash Flow Per Share TTM 0.22 6.5 528.88 - 1.64 4.71
Free Cash Flow Per Share TTM 0.22 5.1 321.24 - 1.21 4.35
Cash Per Share TTM 92.9 % 378.45 % 57241.03 % 5.72 % 292.94 % 1214.64 %
Operating Cash Flow Sales Ratio TTM 16.35 % 32.18 % 18.42 % - 11.07 % 21.24 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.88 % 78.37 % 60.74 % - 73.71 % 92.38 %
Cash Flow Coverage Ratios TTM 52.95 % 43.6 % 16.58 % - 9.78 % -
Price To Free Cash Flows Ratio TTM 3.71 32.51 12.84 - 17.17 32.9
Price To Operating Cash Flows Ratio TTM 3.74 25.58 7.79 - 12.64 30.35
Price Cash Flow Ratio TTM 3.74 25.58 7.79 - 12.64 30.35
Income Statement (TTM)
ASRT ZTS TAK HLN TEVA NBIX
Revenue $0.15B $8.54B $4263.76B $11.3B $15.85B $1.89B
Gross Profit $0.13B $5.83B $2832.26B $6.96B $7.65B $1.85B
Gross Profit Ratio 82.23% 68.28% 66.43% 61.59% 48.25% 97.9%
EBITDA $-0.22B $3.69B $874.6B $2.35B $1.57B $0.36B
Net Income $-0.33B $2.34B $144.07B $1.05B $-0.56B $0.25B
EPS Diluted -4.67 5.07 91.16 0.11 -0.5 2.47
Balance Sheet (MRQ)
ASRT ZTS TAK HLN TEVA NBIX
Long Term Debt $0.04B $6.75B $5029.93B $8.8B $18.48B $0.26B
Total Liabilities $0.15B $9.3B $7834.79B $17.33B $35.35B $1.02B
Total Equity $0.14B $4.99B $7274.01B $16.73B $8.13B $2.23B
Total Investments $0B $0.02B $445.7B $0.07B $0.01B $1.63B
Total Debt $0.04B $6.76B $4843.75B $9.46B $20.15B $0.43B
Total Assets $0.29B $14.29B $15108.79B $34.06B $43.48B $3.25B
Cash Flow Statement (TTM)
ASRT ZTS TAK HLN TEVA NBIX
Net Income $-0.33B $2.34B $144.07B $1.11B $-0.62B $0.25B
Inventory $-0B $-0.36B $-115.74B $-0.13B $0B $0.01B
Dividends Paid $0B $-0.69B $-287.19B $-0.39B $0B $0B
Operating Cash Flow $0.05B $2.35B $716.34B $2.1B $1.37B $0.39B
Capital Expenditure $-0B $-0.73B $-480.73B $-0.34B $-0.53B $-0.03B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 3.955
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 1.56
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 13.32
ALVOW Alvotech 3.3
AMPH Amphastar Pharmaceuticals, Inc. 38.54
AMRX Amneal Pharmaceuticals, Inc. 7.85
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 54.35
AQST Aquestive Therapeutics, Inc. 3.045
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 8.03
AYTU Aytu BioPharma, Inc. 1.64
BDSI BioDelivery Sciences International, Inc. 5.59
ETFs With Exposure to ASRT
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00431 219.777
VTI Vanguard Total Stock Market Index Fund 0 288.45
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00002 128.04
IWN iShares Russell 2000 Value ETF 0.00839 163.29
IWV iShares Russell 3000 ETF 0.00015 332.85
PRFZ Invesco FTSE RAFI US 1500 Small-Mid ETF 0.019 41.5474
VXF Vanguard Extended Market Index Fund 0 191.47
HDG ProShares Hedge Replication ETF 0.000725824 49.22
SPTM SPDR Portfolio S&P 1500 Composite Stock Market ETF 0 71.05
UWM ProShares Ultra Russell2000 0.00145404 41.3
VTHR Vanguard Russell 3000 Index Fund 0 258.51
IWC iShares Micro-Cap ETF 0.02703 125.17
DWAS Invesco DWA SmallCap Momentum ETF 1.223 88.8
URTY ProShares UltraPro Russell2000 0.000690219 48.09
VTWV Vanguard Russell 2000 Value Index Fund 0.01 143.789
EES WisdomTree U.S. SmallCap Earnings Fund 0.0002433 53.54
FDM First Trust Dow Jones Select MicroCap Index Fund 0.17 67.5372
FLQS Franklin LibertyQ U.S. Small Cap Equity ETF 0 41.84
GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF 0 68.7901
OMFS Invesco Russell 2000 Dynamic Multifactor ETF 0.054 39.65
VFMO Vanguard U.S. Momentum Factor ETF 0.05 164.13
VTWO Vanguard Russell 2000 Index Fund 0 88.88
DWMC AdvisorShares Dorsey Wright Micro-Cap ETF 0.32 30.95
PZW.TO Invesco FTSE RAFI Global Small-Mid ETF 0.0094 35.69
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 98.44
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 98.42
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 48.09
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 48.08
VBINX Vanguard Balanced Index Fund Investor Shares 0 48.09
ROSC Hartford Multifactor Small Cap ETF 0.092521 42.89
RYLD Global X Russell 2000 Covered Call ETF 0 16.395
AVUV Avantis U.S. Small Cap Value ETF 0.06 97.28
AVUS Avantis U.S. Equity ETF 0 97.1975
VTSAX Vanguard Total Stock Market Index Fund 0 140.09
AVSU Avantis Responsible U.S. Equity ETF 0.01 66.06
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 143.7
VITSX Vanguard Total Stock Market Index Fund 0 140.11
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000170977 98.42
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 143.71
SWSSX Schwab Small-Cap Index Fund-Select Shares 0.00343662 35.15
AVSC Avantis U.S. Small Cap Equity ETF 0.03 53.8348
VEMPX Vanguard Extended Market Index InstlPlus 0 354.62
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 262.82
RSSL Global X Funds 0 86.07
RFLR Innovator ETFs Trust 0.01 25.33
Unlock